Milestone Pharmaceuticals Inc. (MIST) vs Seer, Inc. (SEER)
Milestone Pharmaceuticals Inc. and Seer, Inc. are both Biotechnology companies. Milestone Pharmaceuticals Inc. and Seer, Inc. are of similar size ($103.6M and $99.0M). Seer, Inc. has the higher net margin (−478.1% vs −1,586.0%) and the lower return on invested capital (−60.8% vs 0.00%). Across the 17 metrics below, Seer, Inc. leads on 14 and Milestone Pharmaceuticals Inc. on 3.
Valuation
Profitability
| Metric | MIST | SEER | Biotechnology median |
|---|---|---|---|
| Gross margin | 13.27% | 47.70% | 65.16% |
| Operating margin | (1,479.69%) | (498.19%) | 0.00% |
| Net margin | (1,586.01%) | (478.05%) | 0.00% |
| Free cash flow margin | (1,163.79%) | (309.34%) | 0.00% |
| Return on equity | (35,522.62%) | (26.45%) | (57.72%) |
| Return on assets | (73.36%) | (23.47%) | (49.22%) |
| Return on invested capital | 0.00% | (60.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack